Cognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Cortical inhibitory neurons and schizophrenia

Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020

Schizophrenia as a Disorder of Neurodevelopment

Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002

Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia

Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938

Cognitive Impairment in Schizophrenia Is the Core of the Disorder

Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 1×

Catching Up on Schizophrenia

Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 833

Gamma Oscillations Correlate with Working Memory Load in Humans

Howard, M. W. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg084 · Cited by 766

Decreased Glutamic Acid Decarboxylase67 Messenger RNA Expression in a Subset of Prefrontal Cortical γ-Aminobutyric Acid Neurons in Subjects With Schizophrenia

Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697

System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis

Bhuiyan, P., Sun, Z., Khan, M. A., Hossain, M. A., Rahman, M. H., & Qian, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25191 · Cited by 14

Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control

Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2008) · Neurotoxicity Research · doi:10.1007/bf03033811 · Cited by 13

The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers

Moschetti, V., Kim, M., Sand, M. S., Wunderlich, G. R., Andersen, G., Feifel, U., Jang, I., Timmer, W., Rosenbrock, H., & Boland, K. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.01.003 · Cited by 13

Activation of D1/D5 receptors ameliorates decreased intrinsic excitability of hippocampal neurons induced by neonatal blockade of N‐methyl‐ d ‐aspartate receptors

Griego, E., Hernández‐Frausto, M., Márquez, L. A., Lara-Valderrábano, L., López‐Rubalcava, C., & Galván, E. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15735 · Cited by 13

Acute Phencyclidine Treatment Induces Extensive and Distinct Protein Phosphorylation in Rat Frontal Cortex

Palmowski, P., Rogowska-Wrzesińska, A., Williamson, J. C., Beck, H. C., Mikkelsen, J. D., Hansen, H. H., & Jensen, O. N. (2014) · Journal of Proteome Research · doi:10.1021/pr4010794 · Cited by 12

Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients

Silver, H., Mandiuk, N., Einoch, R., Susser, E., Danovich, L., Bilker, W. B., Youdim, M. B. H., & Weinreb, O. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000070 · Cited by 12

Agrin and neuregulin, expanding roles and implications for therapeutics

Williams, S., Ryan, C., & Jacobson, C. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.11.003 · Cited by 12

COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia

Shukla, A. A., Jha, M. K., Birchfield, T. R., Mukherjee, S., Gleason, K., Abdisalaam, S., Asaithamby, A., ADAMS-HUET, B. A., Tamminga, C. A., & Ghose, S. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.019 · Cited by 12

Immune markers of social cognitive bias in schizophrenia

Dunne, P. W., Roberts, D. L., Quinones, M. P., Velligan, D. I., Paredes, M., & Walss-Bass, C. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.030 · Cited by 12

Verbal working memory and functional large-scale networks in schizophrenia

Dauvermann, M. R., Moorhead, T. W. J., Watson, A. R., Duff, B. J., Romaniuk, L., Hall, J., Roberts, N., Lee, G. L., Hughes, Z. A., Brandon, N. J., et al. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.10.004 · Cited by 12

Elevated glutamate, glutamine and GABA levels and reduced taurine level in a schizophrenia model using an in vitro proton nuclear magnetic resonance method.

Yang, J., Guo, H., Sun, D., Duan, J., Rao, X., Xu, F., Manyande, A., Tang, Y., Wang, J., & Wang, F. (2019) · PubMed Central · Cited by 11

Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose

Uslaner, J. M., Drott, J. T., Sharik, S. S., Theberge, C. R., Sur, C., Zeng, Z., Williams, D. L., & Hutson, P. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.035 · Cited by 12

Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia

Kantrowitz, J. T., & Javitt, D. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_3 · Cited by 12

NCAM in Neuropsychiatric and Neurodegenerative Disorders

Brennaman, L. H., & Maness, P. F. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9630-z · Cited by 12

Calcium as a Trojan horse in mental diseases—The role of PMCA and PMCA-interacting proteins in bipolar disorder and schizophrenia

Lisek, M., Boczek, T., & Żylińska, L. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.08.005 · Cited by 11

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies

Kositsyn, Y. M., de Abreu, M. S., Kolesnikova, T. O., Lagunin, A. A., Poroikov, V., Harutyunyan, H. S., Yenkoyan, K. B., & Kalueff, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119482 · Cited by 11

Development of Disease-Modifying Treatment of Schizophrenia

Bespalov, A., Klein, C., Behl, B., Groß, G., & Schoemaker, H. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_14 · Cited by 11

Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Vadhan, N. P., Serper, M. R., & Haney, M. (2009) · PubMed · Cited by 11

Loss of dysbindin-1 affects GABAergic transmission in the PFC

Trantham‐Davidson, H., & Lavı́n, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05285-1 · Cited by 10

Overexpression of the schizophrenia risk gene C4 in PV cells drives sex-dependent behavioral deficits and circuit dysfunction

Fournier, L. A., Phadke, R. A., Salgado, M., Brack, A., Nocon, J. C., Bolshakova, S., Grant, J. R., Padró-Luna, N. M., Sen, K., & Cruz‐Martín, A. (2024) · iScience · doi:10.1016/j.isci.2024.110800 · Cited by 8

Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies

Schifani, C., Hafizi, S., Silva, T. M. S., Watts, J. J., Khan, M. S., & Mizrahi, R. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1396205 · Cited by 10

Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study

Camporesi, S., Xin, L., Golay, P., Eap, C. B., Cleusix, M., Cuénod, M., Fournier, M., Hashimoto, K., Jenni, R., Ramain, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02631-4 · Cited by 10

Using iPSC Models to Understand the Role of Estrogen in Neuron–Glia Interactions in Schizophrenia and Bipolar Disorder

de Assis, D. R., Szabó, A., Osete, J. R., Puppo, F., O’Connell, K. S., Akkouh, I. A., Hughes, T., Frei, E., Andreassen, O. A., & Djurovic, S. (2021) · Cells · doi:10.3390/cells10020209 · Cited by 10

From Glutamatergic Dysfunction to Cognitive Impairment: Boundaries in the Therapeutic of the Schizophrenia

Gaspar, P. A., Bustamante, M. L., Rojo, L. E., & Martı́nez, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800784790 · Cited by 9

Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors

Luoni, A., Gass, P., Brambilla, P., Ruggeri, M., Riva, M. A., & Inta, D. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0728-z · Cited by 9

MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals

Grent-‘t-Jong, T., Gajwani, R., Groß, J., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Williams, S. R., & Uhlhaas, P. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.859322 · Cited by 8

Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT

Deakin, J. F. W., John Suckling, A., Dazzan, P., Joyce, E. M., Lawrie, S. M., Upthegrove, R., Husain, N., Chaudhry, I. B., Dunn, G., Jones, P. B., et al. (2019) · Efficacy and Mechanism Evaluation · doi:10.3310/eme06070 · Cited by 8

The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model

Yao, L., Wang, Z., Deng, D., Yan, R., Ju, J., & Zhou, Q. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2306-1 · Cited by 8

Differences in visually induced MEG oscillations reflect differences in deep cortical layer activity

Pinotsis, D. A., & Miller, E. K. (2020) · Communications Biology · doi:10.1038/s42003-020-01438-7 · Cited by 8

Subanesthetic ketamine rapidly alters medial prefrontal miRNAs involved in ubiquitin-mediated proteolysis

Choi, Y., Kim, B., Ham, S., Chung, S., Maeng, S., Kim, H.-S., & Im, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256390 · Cited by 8

Advances in the Management of Treatment- Resistant Schizophrenia

Ballon, J. S., & Lieberman, J. A. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc475 · Cited by 8

Excitation–inhibition imbalance as a common thread linking early Alzheimer's disease with temporal lobe epilepsy

Okechukwu, N. G., Zaccone, C., Barbera, L. L., Nobili, A., & D’Amelio, M. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115581 · Cited by 8

Kynurenine pathway dysregulation in major depressive disorder: the convergence of excitotoxicity, neuroinflammation, and oxidative stress

O’Regan, G., Plummer, Z., Christie, B. R., Shultz, S. R., & Allen, J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03717-2 · Cited by 11

No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (−485C > T) and schizophrenia

Inoue, Y., Shinkai, T., Utsunomiya, K., Sakata, S., Fukunaka, Y., Yamaguchi, W., Yamada, K., Chen, H., Hwang, R., Ohmori, O., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.005 · Cited by 7

From bench to bedside: translating new research from genetics and neuroimaging into treatment development for early‐onset schizophrenia

Kumra, S., Asarnow, R. F., Grace, A. A., Keshavan, M. S., McClellan, J., Sikich, L., & Wagner, A. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00142.x · Cited by 7

Dominant-Negative DISC1 Alters the Dopaminergic Modulation of Inhibitory Interneurons in the Mouse Prefrontal Cortex

Cardarelli, R. A., Martin, R. F., Jaaro-Peled, H., Sawa, A., Powell, E. M., & O’Donnell, P. (2018) · Complex Psychiatry · doi:10.1159/000488030 · Cited by 7

Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures

Gassó, P., Martínez-Pinteño, A., Rodríguez, N., Madero, S., Gómez, M., Segura, À. G., García‐Rizo, C., Morén, C., Mas, S., & Parellada, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032054 · Cited by 6

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months

Wenneberg, C., Glenthøj, B., Glenthøj, L., Fagerlund, B., Krakauer, K., Kristensen, T. D., Hjorthøj, C., Edden, R., Broberg, B., Bojesen, K., et al. (2020) · European psychiatry · doi:10.1192/j.eurpsy.2020.77 · Cited by 7

Accurate performance of a rat model of schizophrenia in the water maze depends on visual cue availability and stability: A distortion in cognitive mapping abilities?

Preissmann, D., Bertholet, L., Sierro, G., Cabungcal, J.-H., & Schenk, F. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.034 · Cited by 6

Riluzole effectively treats psychotic symptoms and improves cognition in 22q11.2 deletion syndrome: A clinical case

Vingerhoets, C., Tse, D. H. Y., & van Amelsvoort, T. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.103705 · Cited by 6

Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice

Higa, K. K., Ji, B., Buell, M. R., Risbrough, V. B., Powell, S. B., Young, J. W., Geyer, M. A., & Zhou, X. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv063 · Cited by 6

Variation at NRG1 genotype related to modulation of small-world properties of the functional cortical network

Lubeiro, A., Gómez‐Pilar, J., Martín-Santiago, Ó., Palomino, A., Fernández, M. I. A., González-Pinto, A. M., Poza, J., Hornero, R., & Molina, V. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0659-0 · Cited by 5

Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia

Martínez-Pinteño, A., Rodríguez, N., Olivares-Berjaga, D., Madero, S., Gómez, M., Prohens, L., García‐Rizo, C., Mas, S., Morén, C., Parellada, E., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114079 · Cited by 5

Maternal–fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findings

Freedman, D., Deicken, R. F., Kegeles, L. S., Vinogradov, S., Bao, Y., & Brown, A. S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.04.012 · Cited by 6

Deep brain stimulation of Hippocampus in Treatment-resistant Schizophrenia (DBS-HITS): protocol for a crossover randomized controlled trial

Lu, C., Zhai, Z., Zhuo, K., Xiang, Q., Xue, J., Zhao, Y., Lang, L., Shao, C., Chen, L., & Liu, D. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06318-6 · Cited by 5

Vulnerability of synapses in the frontal cortex of mice developmentally exposed to an insecticide: Potential contribution to neuropsychiatric disease

Caudle, W. M. (2015) · Neurotransmitter · doi:10.14800/nt.514 · Cited by 4

Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia

Sánchez-Florentino, Z. A., Romero-Martínez, B. S., Flores‐Soto, E., Montaño, L. M., Sommer, B., Valdés‐Tovar, M., Argueta, J., Calixto, E., Aquino‐Gálvez, A., Castillejos-López, M. D. J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12102343 · Cited by 4

Genetic polymorphisms and their association with brain and behavioural measures in heterogeneous stock mice

Janecka, M., Marzi, S. J., Parsons, M. J., Liu, L., Paya-Cano, J. L., Smith, R. G., Fernandes, C., & Schalkwyk, L. C. (2017) · Scientific Reports · doi:10.1038/srep41204 · Cited by 3

Irrelevance by inhibition: Learning, computation, and implications for schizophrenia

Insel, N., Guerguiev, J., & Richards, B. A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006315 · Cited by 4

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia

Vila, È., Pinacho, R., Prades, R., Tarragó, T., Castro, E., Munarriz‐Cuezva, E., Meana, J. J., Eugui-Anta, A., Roldán, M., Vera-Montecinos, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076016 · Cited by 4

Motor Control: Pyramidal, Extrapyramidal, and Limbic Motor Control

McFarland, K. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb001023 · Cited by 4

Modeling Psychiatric Disorders in Experimental Animals

Moore, H. M., & Robbins, T. W. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch17 · Cited by 4

Molecular Etiologies of Schizophrenia: Are We Almost There Yet?

Goldman, D. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11050694 · Cited by 4

Toward a Pluralistic Model for the Schizophrenia Spectrum—Dopamine and Beyond

Keshavan, M. S., Nasrallah, H. A., Abi‐Dargham, A., Grace, A. A., Dc, J., Lewis, D. A., Marder, S. R., Meyer, J. M., Murray, R. M., Öngür, D., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.1684 · Cited by 3

Characterization of iGABASnFR2 for in vivo mesoscale imaging of intracortical GABA dynamics

Rezaei, E., Tohidi, S., Nazari, M., & Abadchi, J. K. (2025) · Neurophotonics · doi:10.1117/1.nph.12.3.035006 · Cited by 4

Modeling Schizophrenia in Neuregulin 1 and ErbB4 Mutant Mice

Lu, Y., Yin, D., Xiong, W., & Mei, L. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_12 · Cited by 3

Function of GABAB and ρ-Containing GABAA Receptors (GABAC Receptors) in the Regulation of Basic and Higher Integrated Sleep-Waking Processes

Gottesmann, C. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_7 · Cited by 3

GABA and Schizophrenia

Kehne, J. H., & Maynard, G. D. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch15 · Cited by 3

Novel electroencephalographic biomarkers for the prediction of responders to an experimental glutamatergic agent in patients with schizophrenia

Siekmeier, P. J., & Coyle, J. T. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03604-z · Cited by 5

Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

Sánchez-Florentino, Z. A., Romero-Martínez, B. S., Flores‐Soto, E., Serrano, H., Montaño, L., Valdés‐Tovar, M., Calixto, E., Aquino‐Gálvez, A., López-Riquelme, G. O., Alvarado, R., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5331 · Cited by 2

Disinhibition of Prefrontal Cortex Neurons in Schizophrenia

Moghaddam, B., & Pehrson, A. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_5 · Cited by 2

Progress in the Exploration and Development of GlyT1 Inhibitors for Schizophrenia

Albert, J. S., & Wood, M. W. (2012) · doi:10.1002/9781118309421.ch8 · Cited by 2

GABAergic neuron dysregulation in a human neurodevelopmental model for major psychiatric disordersPreprint

Guo, Z., Su, Y., Huang, W., Yao, X. S., Hong, Y., Gordin-Kivity, A., Nguyen, H. N., Wen, Z., Rojas, F., Gong, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.23.614564 · Cited by 3

Evaluating neurochemical changes and associated locomotor activity in a double hit schizophrenia model

Shangase, K. B., Luvuno, M., & Mabandla, M. V. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.03.004 · Cited by 1

Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches toward understanding cognitive deficits

Anticevic, A., Krystal, J. H., & Barch, D. M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.013 · Cited by 1

The Kynurenine Pathway at the Interface Between Neuroinflammation, Oxidative Stress, and Neurochemical Disturbances: Emphasis in Schizophrenia

Pineda, B., Campos‐Peña, V., Lugo-Huitrón, R., Rı́os, C., & de la Cruz, V. P. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_13 · Cited by 1

Neurophysiology of Cognitive Dysfunction in Schizophrenia

Haenschel, C., & Linden, D. E. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_18 · Cited by 1

Ketamine Alters Tuning of Neural and Behavioral Spatial Working Memory Precision

Rahmati, M., Moujaes, F., Purg, N., Ji, J. L., Berkovitch, L., Lee, K., Fonteneau, C., Schleifer, C. H., Adkinson, B. D., Savić, A., et al. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.09.016 · Cited by 1

The Contribution of System Xc-to Prefrontal Cortical Mediated Behaviors Associated with Schizophrenia

Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 1

Making a mouse model for schizophrenia:Using the mouse to model the schizophreniasusceptibility gene ZNF804A

Al‐Janabi, T. (2012) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1

Cognition and social behaviour in schizophrenia: An animal model investigating the potential role of nitric oxide

Wass, C. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1

Neurobiological and genetic markers in schizophrenia: a theoretical replication using the Allen Institute for Brain Sciences online database

Gallander, K. (2012) · CSUN ScholarWorks (California State University, Northridge) · Cited by 1

A circuit mechanism for irrationalities in decision-making and NMDA receptor hypofunction: behaviour, computational modelling, and pharmacologyPreprint

Cavanagh, S. E., Lam, N. H., Murray, J. D., Hunt, L. T., & Kennerley, S. W. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/826214 · Cited by 1

Evaluating Novel Muscarinic Acetylcholine Receptor Potentiators for the Treatment of Cognitive Deficits in Schizophrenia

Grannan, M. D. (2016) · Cited by 1

Dynamic changes in the development of prefrontal networks : neuroanatomical findings

Witte, A. V. (2007) · Publikationen an der Universität Bielefeld (Universität Bielefeld)

Genetic and biological contributions to cognitive impairment

Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.011 · Cited by 1

Age, Experience, and NMDA Antagonism: Dynamic Regulation of Parvalbumin Expression in Normal and Chronically Ketamine-Treated Rats

Corriveau, J. A. (2015) · OpenCommons at University of Connecticut (University of Connecticut)

An evaluation of object-place-context recognition as an animal model of episodic memory impairment in schizophrenia

Cozannet, R. L. (2010) · Nottingham ePrints (University of Nottingham)

Schizophrenia: Biological Mechanisms

Perrone‐Bizzozero, N. I., & Bullock, W. M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb669

Role of 5-HT6 receptor in conditioned learning and memory

Woods, S. (2011) · Nottingham ePrints (University of Nottingham)

The prefrontal cortex and information processing : nitric oxide signaling studied in an animal model of schizophrenia

Fejgin, K. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)

The role of the exocyst complex in neural cell adhesion molecule mediated morphogenesis in Mus musculus (Linnaeus, 1758)

Chernyshova, Y. (2008)

P300-Amplitudenreduktion bei Patienten mit Schizophrenie und Gesunden in Abhängigkeit von einem Polymorphismus im NR3A-Gen

Prinz, S. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10537

Bipolar disorder and cognitive functioning : a two-year naturalistic study

Arts, B. M. G. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120511ba

Assessment of Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs using Brain Microdialysis

Sood, P. (2010) · Figshare

Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia

Joseph, J., Gara, M. A., & Silverstein, S. M. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.03.003

A prospective study of cognitive deficits in first episode psychosis, and the response thereof to treatment with Flupenthixol Decanoate

Schoeman, R. (2011) · SUNScholar (Stellenbosch University)

I ett gränsland mellan vanlighet och ovanlighet - en fenomenologisk studie om längvarig psykossjukdom

Syrén, S. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

CorticalOscillatoryActivityIsCriticalforWorkingMemory asRevealedbyDeficitsinEarly-OnsetSchizophrenia

van der Linden, J. A. (2009)

Epigenetic Animal Models of GABAergic Deficit in Mental Disorders

Tueting, P. A., Costa, E., & Guidotti, A. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_11

Evaluating The Effects of Cannabis Dependence and Abstinence on Cortical Inhibition and Working Memory in Schizophrenia

Goodman, M. S. (2015) · TSpace (University of Toronto)

Inhibition of Gamma Oscillations in Healthy Subjects and Patients with Schizophrenia

Farzan, F. (2011) · TSpace (University of Toronto)

A 1H-MRS and Neurocognitive Analysis of Psychotic Symptoms in Stimulant Dependence

Lakusta, B. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3q04w

The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study

Müller, F., Sand, M. S., Wunderlich, G. R., Link, J., Schultheis, C., Dansirikul, C., Sane, R. S., Laszlo, R., & Steinacker, J. M. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03274-6

Schizophrenie

Eggers, C., & Röpcke, B. (2011) · Springer eBooks · doi:10.1007/978-3-642-19846-5_16

FN1, Collagen, MMP-2, and Lumican Associated with ECM Organization with Multiple Signaling Pathways Dysfunction in Schizophrenia Pathogenesis by Network Biology ApproachesPreprint

Bhuiyan, P., Khan, M. A., Sun, Z., & Qian, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2070137/v1

Reflection on the future of autism research: the continuum hypothesis - Réflexion sur l'avenir de la recherche sur l'autisme : l'hypothèse du continuumPreprint

Rebecchi, K. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/egv2p

A Historical and Global Overview of Neuropsychology

Knop-Máximo, C. S. G., Signori, V. D. A., Rodrigues, L. F. D. S., Penha, M. E. F., de Azambuja, D. A., & de Mello, C. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-82614-6_2

A Computational Model for Estimating NMDA Properties from Local Field Potential Spectra

Mancini, G., Martínez‐Cañada, P., & Panzeri, S. (2025) · Lecture notes in computer science · doi:10.1007/978-981-96-3294-7_30

Déséquilibre excitation/inhibition dans la moelle épinière dorsale en situation de douleurs chroniques : rôle des molécules d’adhérence neuroligines

Dolique, T. (2011) · theses.fr (ABES) · doi:10.70675/1e2f2a82zcf75z4066z82c4z9a3b36c872f1

Cognitive dysfunction in schizophrenia: Convergence of -aminobutyric acid and glutamate alterations

Simon, R. P. (n.d.) · UCLA - Biblioteca de Ciencias de la Salud

Cortical inhibitory neurons and schizophrenia

Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297

Deciphering the Disease Process of Schizophrenia: The Contribution of Cortical Gaba Neurons

Lewis, D. A., & Hashimoto, T. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78004-7 · Cited by 106

Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction

Lewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253

Cellular Mechanisms of Psychotic Disorders

Dienel, S. J., & Lewis, D. A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0018